Ribomic Inc. provided consolidated earnings guidance for the year ending March 31, 2024. For the period, the company expects Operating Loss of JPY 1,366 million, Loss of JPY 1,250 and earnings per share of negative JPY 35.05.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
86 JPY | +3.61% | +4.88% | -20.37% |
1st Jan change | Capi. | |
---|---|---|
-20.37% | 20.25M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- 4591 Stock
- News Ribomic Inc.
- Ribomic Inc. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2024